Literature DB >> 7069701

Ring-hydroxylated analogues of lucanthone as antitumor agents.

S Archer, K J Miller, R Rej, C Periana, L Fricker.   

Abstract

A series of ring-alkoxylated and ring-hydroxylated analogues of lucanthone was prepared and tested for antitumor activity. The most biologically interesting members of this group were the 7-hydroxylucanthone derivatives, 50 and 51, which gave T/C values in the NCI P-388 antitumor screen of 188 and 265, respectively. The apparent association constants and delta Tm values for a number of analogue-DNA complexes were determined to ascertain whether there was any quantitative correlation with biological activity. The most that can be said is that intercalation may be a necessary but far from sufficient condition for antitumor activity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7069701     DOI: 10.1021/jm00345a006

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  3 in total

1.  7-Nitro-5H-1-benzothio-pyrano[2,3-b]pyridin-5-one.

Authors:  Muhammad Naeem Khan; M Nawaz Tahir; Misbahul Ain Khan; Islam Ullah Khan; Muhammad Nadeem Arshad
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-03-20

2.  Lucanthone and its derivative hycanthone inhibit apurinic endonuclease-1 (APE1) by direct protein binding.

Authors:  Mamta D Naidu; Rakhi Agarwal; Louis A Pena; Luis Cunha; Mihaly Mezei; Min Shen; David M Wilson; Yuan Liu; Zina Sanchez; Pankaj Chaudhary; Samuel H Wilson; Michael J Waring
Journal:  PLoS One       Date:  2011-09-15       Impact factor: 3.240

3.  Lucanthone Targets Lysosomes to Perturb Glioma Proliferation, Chemoresistance and Stemness, and Slows Tumor Growth In Vivo.

Authors:  Daniel P Radin; Gregory Smith; Victoria Moushiaveshi; Alexandra Wolf; Robert Bases; Stella E Tsirka
Journal:  Front Oncol       Date:  2022-04-14       Impact factor: 5.738

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.